ATE437635T1 - Medium zur radikalen therapie von tumoren, von entzündungsprozessen, von pilzinfektionen und von anderen affektionen der geweben; diagnostische und prophylaktische verfahren sowie deren implementierung - Google Patents

Medium zur radikalen therapie von tumoren, von entzündungsprozessen, von pilzinfektionen und von anderen affektionen der geweben; diagnostische und prophylaktische verfahren sowie deren implementierung

Info

Publication number
ATE437635T1
ATE437635T1 AT02713949T AT02713949T ATE437635T1 AT E437635 T1 ATE437635 T1 AT E437635T1 AT 02713949 T AT02713949 T AT 02713949T AT 02713949 T AT02713949 T AT 02713949T AT E437635 T1 ATE437635 T1 AT E437635T1
Authority
AT
Austria
Prior art keywords
tumors
diagnostic
implementation
medium
inflammatory processes
Prior art date
Application number
AT02713949T
Other languages
English (en)
Inventor
Vladimir Panchev
Marieta Pancheva
Adelina Souvandjieva
Original Assignee
Vladimir Panchev
Marieta Pancheva
Adelina Souvandjieva
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3928598&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE437635(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vladimir Panchev, Marieta Pancheva, Adelina Souvandjieva filed Critical Vladimir Panchev
Application granted granted Critical
Publication of ATE437635T1 publication Critical patent/ATE437635T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT02713949T 2001-12-12 2002-04-08 Medium zur radikalen therapie von tumoren, von entzündungsprozessen, von pilzinfektionen und von anderen affektionen der geweben; diagnostische und prophylaktische verfahren sowie deren implementierung ATE437635T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BG106215A BG106215A (bg) 2001-12-12 2001-12-12 Средство за радикално лечение на туморите, възпалителни процеси, гъбични образувания и други изменения на тъканите, диагностика и профилактика и методи за прилагането му
PCT/BG2002/000006 WO2003049728A1 (en) 2001-12-12 2002-04-08 Medium for radical treatment of tumors, inflammatory processes, fungal infections and other affections of the tissues, diagnostic and prophylactic and method of its implementation

Publications (1)

Publication Number Publication Date
ATE437635T1 true ATE437635T1 (de) 2009-08-15

Family

ID=3928598

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02713949T ATE437635T1 (de) 2001-12-12 2002-04-08 Medium zur radikalen therapie von tumoren, von entzündungsprozessen, von pilzinfektionen und von anderen affektionen der geweben; diagnostische und prophylaktische verfahren sowie deren implementierung

Country Status (11)

Country Link
US (1) US20050119344A1 (de)
EP (1) EP1455772B1 (de)
AT (1) ATE437635T1 (de)
AU (1) AU2002245956A1 (de)
BG (1) BG106215A (de)
DE (1) DE60233161D1 (de)
DK (1) DK1455772T3 (de)
EA (1) EA010029B1 (de)
ES (1) ES2332583T3 (de)
PT (1) PT1455772E (de)
WO (1) WO2003049728A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA201700154A1 (ru) * 2014-10-20 2017-08-31 Товарищество С Ограниченной Ответственностью "Фармацевтическая Компания "Ромат" Фармацевтический состав лечебно-профилактического действия и способ его приготовления
KR20190137909A (ko) * 2017-04-22 2019-12-11 차이동 친 세포 해당과 글루타민 대사과정 동시 억제방법 및 응용

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4147775A (en) * 1976-10-06 1979-04-03 Schwartz Stephen H Antiseptic composition
LU86573A1 (de) * 1986-09-08 1988-04-05 Chimicasa Gmbh Verfahren und praeparat zum inaktivieren von viren innerhalb lebender menschlicher oder tierischer organismen
US4927813A (en) * 1988-03-08 1990-05-22 Bernstein Joel E Method and composition for treating pediculosis capitis
DE69312503D1 (de) * 1992-09-22 1997-09-04 Arda Technologies Co Antimikrobielle zusammensetzung und verfahren zu ihrer herstellung
US5879880A (en) * 1996-04-30 1999-03-09 Peregrine Pharmaceuticals, Inc. Method of diagnosing by determining formic acid to nicotinic acid ratio
US6231840B1 (en) * 1998-02-13 2001-05-15 Carol J. Buck Compositions and methods for the topical treatment of nail fungi conditions
SE513436C2 (sv) * 1999-01-21 2000-09-11 Astrid Agholme Användning av en beredning innehållande myrsyra för framställning av ett läkemedel för behandling av vårtor, orsakade av Papillomavirus

Also Published As

Publication number Publication date
EP1455772B1 (de) 2009-07-29
EA200400783A1 (ru) 2005-04-28
BG106215A (bg) 2003-06-30
AU2002245956A1 (en) 2003-06-23
EA010029B1 (ru) 2008-06-30
DE60233161D1 (de) 2009-09-10
US20050119344A1 (en) 2005-06-02
PT1455772E (pt) 2009-11-03
WO2003049728A1 (en) 2003-06-19
ES2332583T3 (es) 2010-02-09
DK1455772T3 (da) 2009-11-30
EP1455772A1 (de) 2004-09-15

Similar Documents

Publication Publication Date Title
BRPI0414455A (pt) métodos para usar células regenerativas no tratamento de doença vascular periférica e distúrbios afins
BRPI0213786B8 (pt) peptídeos efetivos no tratamento de tumores e outras condições que requerem a remoção ou destruição de células
DE60135755D1 (de) Verbindungen und methoden zur behandlung von hautverletzungen
EP2305276A3 (de) Zellen aus Lipoaspirat und ihre Verwendung zur Therapie
BR0309890A (pt) Composição farmacêutica contendo plasma sanguìneo, ou soro sanguìneo utilizada no tratamento de lesões, bem como seu método e processo de aplicação
WO2005065242A3 (en) Method of treating cancer using platelet releasate
CY1110503T1 (el) Πενταμιδινη για θεραπεια καρκινου
WO2022271810A3 (en) Bicyclic peptidyl pan-ras inhibitors
ATE415962T1 (de) Verwendung von asiatsäure oder asiaticosid zur behandlung von krebs
DE60137635D1 (de) Verwendung von allopurinol zur behandlung von bluthochdruck
ATE430572T1 (de) Verwendung von spongosin (2-methoxyadenosin) zur behandlung von schmerzen, insbesondere hyperalgesie
BR0313117A (pt) Método para a produção de um efeito redutor de permeabilidade vascular e/ou antiangiogênico em um animal de sangue quente tal como um humano, método para o tratamento de um câncer em um animal de sangue quente tal como um humano, composição farmacêutica, kit, e, uso de zd6474 ou de um seu sal farmaceuticamente aceitável e de zd1839 ou de um seu sal farmaceuticamente aceitável
ATE399002T1 (de) Pharmazeutische zubereitungen für die behandlung von läsionen der haut und schleimhäute und diese verwendende verfahren und kits
DE60218843D1 (de) Verfahren zur identifizierung von mitteln zur behandlung von diabetes
DE60309887D1 (de) Kombination von einem aromatasehemmer mit einem bisphosphonat
ATE222101T1 (de) Verwendung von selegilin oder desmethylselegilin zur behandlung von wunden, verbrennungen und hautschäden
BRPI0517953A (pt) uso de zd 6474, ou de um sal farmaceuticamente aceitável do mesmo, e de um antiandrógeno, composição farmacêutica, kit, e, método para a produção de um efeito da redução da permeabilidade vascular e/ou antiangiogênico em um animal de sangue quente
ATE437635T1 (de) Medium zur radikalen therapie von tumoren, von entzündungsprozessen, von pilzinfektionen und von anderen affektionen der geweben; diagnostische und prophylaktische verfahren sowie deren implementierung
DE69932922D1 (de) Verwendung von alkansäuren-enthaltenden zusammensetzungen zur behandlung von nagelpilz-erkrankungen
BRPI0412408A (pt) métodos para a produção de um efeito de redução antiangiogênico e/ou de permeabilidade vascular e para o tratamento de um cáncer em um animal de sangue quente tal como um ser humano, composição farmacêutica, kit, e uso de azd2171 ou um sal farmaceuticamente aceitável deste e zd1839 ou um sal farmaceuticamente aceitável deste
DE50100833D1 (de) Verwendung von 2-methyl-thiazolidin-2,4-dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen
ATE386029T1 (de) Urokinase-inhibitoren
DE602004030661D1 (de) Verwendung von kahalalide verbindungen zur herstellung eines arzneimittels zur behandlung von psoriasis
ATE385798T1 (de) Pharmazeutische zubereitungen enthaltend azd 2171 und zd 6126 und verwendungen
US6932966B1 (en) Topically applied reconstituted ocean water mixture and method of producing and using the mixture

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1455772

Country of ref document: EP